2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Adrenal Gland Neoplasms
5
Adrenal incidentaloma
3
Pheochromocytoma
2
Hypertension
2
Cushing Syndrome
2
Urinary Bladder Neoplasms
1
Osteoporosis
1
Obesity
1
Hypokalemia
1
Hypercholesterolemia
1
Hyperaldosteronism
1
Diabetes Mellitus
1
Carcinoma, Renal Cell
1
Adrenocortical Carcinoma
1
Adrenocortical Adenoma
1
Interventions
Radiofrequency Ablation
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Staining and Labeling
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Prednisone
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Observation
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Dexamethasone
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperaldosteronism
×
Adrenalectomy
×
Clear all
NCT07470580
2026-03-13
ADERADHTA2
University Hospital, Toulouse
Phase NA
Not yet recruiting
134 enrolled